Biobehavioral pathways linking stress and cancer progression

连接压力和癌症进展的生物行为途径

基本信息

项目摘要

DESCRIPTION (provided by applicant): In 2010, over 11.5 million people were living with cancer in the United States and over 500,000 new cases are expected to be diagnosed each year. The life threatening and unpredictable course of cancer makes it a particularly stressful lif experience. Stress may be defined as when the demands being placed on an individual are perceived as threatening or harmful and exceed the resources available to manage the stressor. Decades of research have shown that stress is associated with maladaptive health behaviors (e.g., high fat diet) as well as increased risk of morbidity and mortality. The goal of this prospective study is to examine the mechanistic pathways linking chronic stress and engagement in maladaptive health behaviors with disease progression in people diagnosed with hepatobiliary carcinoma. The proposed study will begin to elucidate the biobehavioral pathways linking stress and health behaviors with disease progression in the context of cancer. The aims and hypotheses of this study are: (1) to investigate predictors of the psychological and physiological stress response to a diagnosis or recurrence of hepatobilary carcinoma. We expect that people who report a past history of early adverse events (e.g., death of a loved one, abuse) will report higher levels of perceived stress and elevations in biomarkers of inflammation. Early adverse events are expected to be associated with an earlier age of onset of these maladaptive health behaviors (e.g., alcohol use) and contributed to the risk factors associated with the development of cancer (e.g., cirrhosis); (2) to examine the dynamic link between stress and health behaviors over time in people diagnosed with hepatobiliary carcinoma. We expect high levels of chronic stress to be associated with (a) attempts to change maladaptive health behaviors or adopt adaptive health behaviors, or (b) attempts to decrease physiological arousal by continued use or re-initiation of maladaptive health behaviors. We expect that a positive illness perception will mediate the link between perceived stress and health behaviors and that problem focused coping and social support will moderate this relationship. Engaging in maladaptive behaviors to reduce stress will be mediated by negative illness perceptions and moderated by emotion focused coping and lack of social support; (3) to explore the links between stress, health behaviors, and biomarkers of inflammation on disease progression. We expect that patients with a combination of chronic stress and/or engagement in maladaptive health behaviors will have abnormal levels of biomarkers of inflammation and more rapid tumor growth and development of intra- and extra-hepatic metastases when compared to patients with lower levels of perceived stress or adaptive health behaviors. The proposed study is responsive to the RFA which request studies that will "examine mediating and moderating factors such as individual demographic (age, gender/sex, ethnicity) and psychological (vulnerabilities, resilience) differences, risk factors, early exposure to stress". The findings of this study are expected to lead to potential psychological and behavioral targets for interventions to improve quality of life and reduce mortality in people diagnosed with cancer.
描述(由申请人提供):2010年,美国有超过1150万人患有癌症,预计每年将诊断出超过50万例新病例。癌症的生命威胁和不可预测的过程使其成为一个特别紧张的生活经历。压力可以被定义为当对个人的要求被认为是威胁或有害的,并超过可用的资源来管理压力。几十年的研究表明,压力与适应不良的健康行为有关(例如,高脂肪饮食)以及发病率和死亡率风险增加。这项前瞻性研究的目的是检查慢性压力和参与适应不良的健康行为与诊断为肝胆癌的人的疾病进展之间的机制途径。拟议的研究将开始阐明在癌症背景下将压力和健康行为与疾病进展联系起来的生物行为途径。本研究的目的和假设是:(1)探讨肝胆癌诊断或复发后心理和生理应激反应的预测因素。我们希望报告早期不良事件既往史的人(例如,亲人死亡、虐待)将报告更高水平的感知压力和炎症生物标志物的升高。早期不良事件预计与这些适应不良健康行为的发病年龄较早相关(例如,酒精使用)并促成与癌症发展相关的风险因素(例如,肝硬化);(2)检查压力和健康行为之间的动态联系,随着时间的推移,在人们诊断为肝胆癌。我们认为高水平的慢性压力与以下因素有关:(a)试图改变适应不良的健康行为或采取适应性健康行为,或(B)试图通过持续使用或重新开始适应不良的健康行为来降低生理唤醒。我们预期,积极的疾病感知将介导感知压力和健康行为之间的联系,而以问题为中心的应对和社会支持将缓和这种关系。参与适应不良行为以减轻压力将通过负面疾病感知来介导,并通过情绪集中应对和缺乏社会支持来调节;(3)探索压力,健康行为和炎症生物标志物对疾病进展的关系。我们预计,与具有较低水平的感知压力或适应性健康行为的患者相比,具有慢性压力和/或参与适应性不良健康行为的患者将具有异常水平的炎症生物标志物和更快的肿瘤生长以及肝内和肝外转移的发展。拟议的研究是对RFA的回应,RFA要求研究“审查中介和调节因素,如个人人口统计(年龄,性别/性别,种族)和心理(脆弱性,复原力)差异,风险因素,早期暴露于压力”。这项研究的结果有望为干预措施提供潜在的心理和行为目标,以改善癌症患者的生活质量并降低死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JENNIFER L. STEEL其他文献

JENNIFER L. STEEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JENNIFER L. STEEL', 18)}}的其他基金

Diversity Supplement to R01-Palliative care intervention for socioeconomically disadvantaged cancer patients
R01 的多样性补充 - 针对社会经济弱势癌症患者的姑息治疗干预
  • 批准号:
    10063723
  • 财政年份:
    2020
  • 资助金额:
    $ 41.78万
  • 项目类别:
Palliative care intervention for socioeconomically disadvantaged cancer patients
对社会经济弱势癌症患者的姑息治疗干预
  • 批准号:
    9901463
  • 财政年份:
    2016
  • 资助金额:
    $ 41.78万
  • 项目类别:
Biobehavioral pathways linking stress and cancer progression
连接压力和癌症进展的生物行为途径
  • 批准号:
    8725612
  • 财政年份:
    2012
  • 资助金额:
    $ 41.78万
  • 项目类别:
Biobehavioral pathways linking stress and cancer progression
连接压力和癌症进展的生物行为途径
  • 批准号:
    8401990
  • 财政年份:
    2012
  • 资助金额:
    $ 41.78万
  • 项目类别:
Analysis of the Cytokine-Immunological Model of a Cancer-Related Symptom Cluster
癌症相关症状簇的细胞因子免疫学模型分析
  • 批准号:
    7569035
  • 财政年份:
    2008
  • 资助金额:
    $ 41.78万
  • 项目类别:
Analysis of the Cytokine-Immunological Model of a Cancer-Related Symptom Cluster
癌症相关症状簇的细胞因子免疫学模型分析
  • 批准号:
    7387021
  • 财政年份:
    2008
  • 资助金额:
    $ 41.78万
  • 项目类别:
Comprehensive Electronic Support System for Treatment of Cancer-Related Symptoms
用于治疗癌症相关症状的综合电子支持系统
  • 批准号:
    7925358
  • 财政年份:
    2006
  • 资助金额:
    $ 41.78万
  • 项目类别:
Comprehensive Electronic Support System for Treatment of Cancer-Related Symptoms
用于治疗癌症相关症状的综合电子支持系统
  • 批准号:
    7271917
  • 财政年份:
    2006
  • 资助金额:
    $ 41.78万
  • 项目类别:
Comprehensive Electronic Support System for Treatment of Cancer-Related Symptoms
用于治疗癌症相关症状的综合电子支持系统
  • 批准号:
    7150064
  • 财政年份:
    2006
  • 资助金额:
    $ 41.78万
  • 项目类别:
Comprehensive Electronic Support System for Treatment of Cancer-Related Symptoms
用于治疗癌症相关症状的综合电子支持系统
  • 批准号:
    7473986
  • 财政年份:
    2006
  • 资助金额:
    $ 41.78万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.78万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.78万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了